Actively Recruiting
Study of Phexxi Vaginal Gel Effects on Vaginal Microbiome and Symptoms in Women Aged 18 to 54
Led by Queen's Medical Center · Updated on 2026-02-20
22
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how the contraceptive gel Phexxi might change the vaginal microbiome, focusing on whether it increases helpful lactic acid-producing bacteria. The study aims to see if this change could help prevent recurring bacterial vaginosis BV and vaginal yeast infections. This early-phase, single-center trial uses a before-and-after design to measure changes in vaginal bacteria and symptoms over time. Participants will use Phexxi, an intravaginal gel, twice weekly for four weeks. They will receive 8 pre-filled vaginal gel applicators with instructions for use. The study involves three self-collected vaginal swab samples one before starting the gel, one after 30 days of use, and a final one 30 days after completing the treatment. Participants will also keep a diary of symptoms and events like intercourse or menstruation during the treatment period. Participants will self-collect vaginal swabs at home and send them to the research lab for freezing and DNA sequencing to analyze bacterial changes. They will complete surveys about symptoms and satisfaction with the gel at each collection point. Researchers will monitor changes in vaginal bacteria and symptoms of vulvovaginitis. The entire participation lasts about 60 days, including treatment and follow-up. The study is led by Queens Medical Center and aims to understand Phexxis effects on vaginal health.
CONDITIONS
Brief Title
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
Research Team
O
Olivia H Manayan, MD, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here